Peter Black, MD, FACS, FRCSC, presented “Clinical Implications of Similarities and Differences Between Upper-Tract and Bladder Urothelial Carcinoma” for the Grand Rounds in Urology audience in November, 2019.

How to cite: Black, Peter. “Clinical Implications of Similarities and Differences Between Upper-Tract and Bladder Urothelial Carcinoma” November, 2019. Accessed Oct 2020. https://grandroundsinurology.com/clinical-implications-of-similarities-and-differences-between-upper-tract-and-bladder-urothelial-carcinoma/

Clinical Implications of Similarities and Differences Between Upper-Tract and Bladder Urothelial Carcinoma – Summary:

Peter Black, MD, FACS, FRCSC, a Urologic Oncologist at Vancouver General Hospital, a Senior Research Scientist at the Vancouver Prostate Centre, and a Professor in the Department of Urologic Sciences at the University of British Columbia, examines key differences between upper-tract and bladder urothelial carcinomas, and their impact on diagnosis and treatment of each respective disease. He discusses subtle molecular differences between each disease, how these variations’ relationship to genetic alterations could lead to marker-based therapy, as well as treatments that are effective in treating both diseases.